Take 5 Traffic Stabilizes and Margins Expand as Leverage Nears Target, Setting Up a Capital-Allocation Catalyst
Key Takeaways
- A clean beat with the right composition: revenue of $484.4M (+8.2% YoY) topped consensus, adjusted EPS of $0.30 crushed the $0.24 Street mark, and Take 5 posted its 23rd straight comp quarter at +4.5% (12.5% two-year stack) while expanding segment margin 120bps to 33.9%.
- The Q4 scare did not escalate. The traffic softening in sub-$50K and newer-customer cohorts persisted but did not worsen ("nothing's changed from a trends perspective, pretty stable"), it is churn rather than interval elongation, and the core customer is resilient with check, attachment, and premium mix all rising.
- Net leverage improved to 3.2x, essentially at the 3.0x year-end target, and management for the first time framed the post-3.0x plan concretely: no need for deferred capex, limited appetite to delever further, and shareholder returns explicitly on the table, with a framework to be communicated later this year.
- The full-year guide was reiterated, restatement costs came in below plan in Q1 ($9.1M), remediation of the material weaknesses is progressing, and ex-restatement the adjusted EBITDA margin expanded ~50bps; a new CMO (ex-Popeyes/PepsiCo) was hired to build marketing into a core capability.
- Rating: Upgrading to Outperform from Hold. The two conditions we set for an upgrade are now in view: Take 5 traffic stabilized rather than deteriorating, and the deleveraging is all but complete with a capital-return catalyst approaching against a de-rated stock. The risk/reward has tilted favorably.
Results vs. Consensus
| Metric (Q1 2026) | Actual | Consensus | Beat/Miss | Magnitude |
|---|---|---|---|---|
| Revenue | $484.4M | $481.3M | Beat | +0.6% |
| Adj. EBITDA | $104.1M | ~$97.6M | Beat | +6.7% |
| Adj. EBITDA margin | 21.5% | n/a | Down | -140bps YoY (incl. restatement) |
| Operating income | $67.4M | n/a | Up | +$12.7M YoY |
| EPS (GAAP, cont. ops) | $0.14 | n/a | Up | from $0.08 |
| Adj. Diluted EPS (cont. ops) | $0.30 | $0.24 | Beat | +24.4% |
| Free cash flow | $30.3M | n/a | Up | +$13.0M YoY |
Quality of Beat/Miss
- Revenue: High quality. The +8.2% is unit- and comp-driven, with all three segments posting positive same-store sales and Take 5 revenue up 10%. There is no acquisition noise, and the number is clean of the divested car wash businesses.
- Margins: Better than the headline. The reported 21.5% margin is down 140bps year-over-year, but that is entirely a restatement-cost artifact ($9.1M in the quarter); excluding those non-recurring costs, adjusted EBITDA margin expanded roughly 50bps. The underlying operating margin is improving, not deteriorating.
- EPS: High quality. Adjusted EPS of $0.30 beat by 24% on genuine operating leverage plus a $12.8M year-over-year drop in interest expense from deleveraging. Take 5 EBITDA growth of 13.6% flatters slightly on the lapping of a ~$4.5M restatement-related inventory charge; adjusting for that, Take 5 EBITDA still grew ~8.5%, a clean underlying figure.
Segment Performance
| Segment (Q1 2026) | Revenue | Same-Store Sales | Adj. EBITDA | Adj. EBITDA Margin | Notable |
|---|---|---|---|---|---|
| Take 5 | $323.2M | +4.5% | $109.5M | 33.9% | 23rd straight comp; margin +120bps; +13.6% EBITDA |
| Franchise Brands | $69.4M | +0.9% | $41.4M | ~60% | Meineke-led; positive comp; moderation guided into 2H |
| Auto Glass Now | $63.1M | +7.2% | $5.9M | 9.4% | Margin +40bps; sequential growth across channels |
| Corporate & Other | $28.8M | n/a | ($52.7M) | n/a | Carries restatement/corporate costs |
Take 5 Oil Change
Take 5 delivered the quarter the thesis needed after the Q4 scare: a 23rd straight comp at +4.5% (12.5% on a two-year stack), revenue up 10%, EBITDA up 13.6% (~8.5% adjusting for a lapped inventory charge), and, most importantly, segment margin expanding 120bps year-over-year to 33.9%. The traffic moderation flagged last quarter is still present and now specifically attributed to households earning under $50K, but management characterized it as stable rather than deteriorating, and as churn out of two identifiable cohorts rather than a lengthening of oil-change intervals. Average check, attachment, and premium mix all continued to rise, and NPS held in the high 70s.
"We continue to see a bit of moderation with two very specific groups of customers... Honestly, nothing's changed from a trends perspective. Things are pretty stable on that front... when we look at our core customer and when we look frankly across all other customer types, what we're seeing is resilience." — Danny Rivera, President and CEO
Assessment: This is the decisive read. The bear case coming out of Q4 required the value-cohort softening to widen; instead it held steady while margin expanded and check strengthened. Confirming that intervals are not elongating (the true demand-destruction signal) is the single most reassuring data point on the call. The core Take 5 pillar moves back from at-risk toward on-track.
Franchise Brands
The cash engine posted a +0.9% comp, led by Meineke, with collision showing sequential improvement off the Q4 trough. Revenue was roughly flat (the sale of two remaining company-operated collision locations was a small drag), and EBITDA dipped $1.5M to $41.4M on technology costs and growth investments, holding a ~60% margin. Management guided the segment's comp to moderate into the back half as collision stabilizes rather than bounces back, while insisting margins stay strong.
"I love it when we post a 1% comp quarter, obviously, but at the end of the day, what I love more is 60% margins, and irrespective of the moderation of the top line into the back half of the year, we continue to expect really strong margins from that segment." — Danny Rivera, President and CEO
Assessment: The franchise segment continues to do its one job, generating high-margin cash to fund deleveraging, and the collision normalization is a modest tailwind. Management's framing that comp matters less than margin here is correct for this business's role in the portfolio. The bear point stays contained.
Auto Glass Now
AGN grew revenue 6%, comps 7.2%, and EBITDA 12% to $5.9M, expanding margin 40bps to 9.4% with sequential gains across retail, commercial, and insurance channels. It remains small but is now compounding at an attractive rate with a clear expansion path via carrier relationships and share gains.
Assessment: The second consecutive quarter of steady AGN progress supports the optionality case. At ~$6M of quarterly EBITDA it is still immaterial, but the margin trajectory and channel breadth suggest it can become a genuine third growth lever over a multi-year horizon.
Key Topics & Management Commentary
Overall Management Tone: Steady and constructive, with the defensiveness of the restatement quarter giving way to a more forward-leaning posture centered on Take 5's margin expansion and the approaching leverage milestone. Management was measured about the value-cohort traffic softness and the guided Q2 moderation, pairing candor about macro pressure with confidence in the core. The tone shift from Q4's damage-control mode to Q1's execution-and-capital-allocation framing was the clearest quarter-over-quarter change.
Take 5 Traffic: Stable, Not Deteriorating
The most-scrutinized topic was whether the Q4 traffic softening had widened. Management held that it had not, narrowing the affected group to sub-$50K households and framing it as churn rather than reduced service frequency.
"If the question is, are we seeing intervals go up? No. Oil change intervals have been stable for some time now... This is not an elongation of when customers are coming in. What we're seeing is with two very specific types of customers, a bit more churn." — Danny Rivera, President and CEO
Assessment: The interval point is the analytical crux. Stable intervals mean the non-discretionary demand thesis is intact and the softness is a customer-acquisition/retention challenge in a specific cohort, precisely the kind of problem the new CMO and surgical promotions are meant to address. This is the evidence that the Q4 bear escalation has, for now, been arrested.
Deleveraging to 3.2x and the Post-3.0x Framework
Net leverage reached 3.2x, and for the first time management gave real texture to what happens after 3.0x, naming shareholder returns explicitly and downplaying further deleveraging.
"I'm not sure once we get to 3x if there's a ton of appetite to delever significantly further... There's also possibility of returning cash to shareholders... as we get closer to the end of the year, we'll be in a position to communicate." — Michael Diamond, CFO
Assessment: This is the catalyst we have been waiting four quarters for. With leverage essentially at target and management signaling limited appetite to delever further, the free-cash-flow allocation debate shifts toward buybacks, and a de-rated stock is the ideal backdrop for that. The framework's expected year-end reveal is a concrete, near-term catalyst.
Material-Weakness Remediation Progress
The CFO opened with a remediation update, framing it as a multi-quarter process with meaningful early progress against detailed work plans.
"Our team has made meaningful early progress executing against detailed remediation work plans for each material weakness, and we remain committed to strengthening our control environment as we move forward." — Michael Diamond, CFO
Assessment: Leading with remediation rather than burying it signals the governance overhang is being managed transparently. It remains a multi-quarter effort, and a clean audit is the milestone that fully lifts the overhang, but the direction and disclosure are right. The bear point is easing at the margin.
Marketing as a New Enterprise Capability
Management highlighted the hire of a new CMO to centralize and professionalize marketing across the portfolio, and detailed a shared CRM platform used to drive frequency and retention.
"We have centralized marketing leadership under Bart to build a more integrated, data-driven, and scalable marketing organization that can accelerate growth, improve customer acquisition efficiency, strengthen customer retention." — Danny Rivera, President and CEO
Assessment: Directly responsive to the value-cohort churn problem. A professionalized marketing function plus the shared CRM engine is the structural answer to customer-acquisition-and-retention softness, and the platform-level scale is a genuine advantage smaller single-brand competitors lack. A sensible investment, though the payoff is prospective.
Guidance & Outlook
| Metric (FY2026) | Prior Guide | New Guide | Change |
|---|---|---|---|
| Revenue | ~$1.95 - $2.05B | ~$1.95 - $2.05B | Reiterated |
| Adj. EBITDA | ~$430 - $460M | ~$430 - $460M | Reiterated (incl. $35-45M restatement) |
| Adj. Diluted EPS | ~$1.15 - $1.25 | ~$1.15 - $1.25 | Reiterated |
| Same-store sales | Flat to 2% | Flat to 2% | Reiterated |
| Net store growth | ~160 - 190 | ~160 - 190 | Reiterated |
| Free cash flow | $125 - $145M | $125 - $145M | Reiterated |
The full-year outlook was reiterated in full, which after a beat is a modestly conservative posture consistent with management's careful credibility management post-restatement. The more useful color was on Q2: management guided moderation across all brands, with Take 5 comps in the mid-3% range (roughly 10% on a two-year stack), franchise moderating from Q1's +0.9%, and restatement costs exceeding $15M as the 10-K and Q1 10-Q filings plus securitization financials concentrate in the quarter. Adjusted EBITDA margin is expected to be pressured relative to Q1's 21.5% as a result.
Implied 2026 shape: Restatement costs front-load into Q1-Q2, so first-half margins are artificially depressed while the underlying business improves; Q3 seasonality (peak driving season) plus fixed-cost leverage should drive the second-half recovery. The reiterated guide and the below-plan Q1 restatement spend both point to conservatism baked in.
Guidance style: Conservative and consistent. Reiterating after a beat, guiding Q2 moderation explicitly, and disclosing restatement costs quarter-by-quarter all reinforce that management is under-promising while the restatement noise clears.
Analyst Q&A Highlights
The Traffic Moderation and Whether It Is Spreading
The opening exchange pressed on the traffic softening, its Q2 trajectory, and whether it extended beyond the newer and lower-income cohorts.
Q: "Can you just talk a little bit more about the moderation you're seeing in traffic from some of your customers, and I guess how it's trending during 2Q, and if there's anything you can talk about in your other demographics outside of the new customers and the lower income customers?"
— Mark Jordan, Goldman Sachs
A: "We continue to see a bit of moderation with two very specific groups of customers... nothing's changed from a trends perspective. Things are pretty stable on that front... check is up, attachment rates are up, premiumization is up... we're seeing a resilient consumer with a bit of moderation across two specific groups." — Danny Rivera, President and CEO
Assessment: The "stable, contained to two groups, core resilient" answer is exactly what the thesis needed. The confirmation that check and attachment are still rising means the mix and margin engine is intact even as the value cohort churns.
Franchise Comp Inflection and Collision Sustainability
Questioning turned to the positive franchise comp and whether collision can stabilize as insurance premiums ease.
Q: "Franchise Brands comps inflected positive this quarter. Can you maybe talk a bit about how sustainable that is and what you're seeing more specifically in the collision space?... what could be the key unlock to really stabilize that segment going forward?"
— Phillip Blee, William Blair
A: "We're expecting some moderation for the segment towards the back half of the year... we're really expecting [collision to be] a year of stabilization, not so much a year of bounce back... for us, Franchise Brands is all about cash... what I love more is 60% margins." — Danny Rivera, President and CEO
Assessment: Honest that the franchise comp moderates from here, while re-anchoring the segment's value on cash generation rather than growth. Setting collision expectations at "stabilization, not bounce-back" is appropriately conservative and consistent with prior quarters.
Post-3.0x Capital Allocation
A recurring line of questioning finally drew concrete texture on what happens to free cash flow after the leverage target is reached.
Q: "After you've hit your target, can you just talk a bit more about your plans for free cash flow? Are there areas of the business that need a bit more investment, more debt paydown, or is there some shareholder returns that you're thinking about?"
— Phillip Blee, William Blair
A: "I don't think there's any sort of deferred CapEx or anything we need to go into to catch up... There's also possibility of returning cash to shareholders... I'm not sure once we get to 3x if there's a ton of appetite to delever significantly further." — Michael Diamond, CFO
Assessment: The most catalyst-relevant answer of the call. Explicitly naming shareholder returns and downplaying further deleveraging is the clearest signal yet that the free-cash-flow story pivots to capital return, the re-rating trigger we flagged three quarters running.
Pricing and Promotional Flexibility
An exchange probed how management would use pricing and promotions to address the value-cohort softness without impairing demand.
Q: "Given some of the softer trends you're seeing in traffic on the Take 5 side, can you talk about how you might be thinking about pricing and how much flexibility that you have there without necessarily impacting demand?"
— Skylar Tennant (for Simeon Gutman), Morgan Stanley
A: "We're talking about moderation with two very specific groups of customers that are very readily identifiable. That sounds like a use case where the arrow... of surgical promotions tends to make sense... I wouldn't take that as any kind of a broad shift in pricing strategy." — Danny Rivera, President and CEO
Assessment: Surgical, targeted promotion to an identifiable cohort is the right, margin-protective response, and the explicit disavowal of a broad pricing shift preserves the premium positioning. It shows management has a concrete tool aimed at the exact problem.
SG&A Efficiency and the Cleaner Portfolio
Questioning turned to whether the simpler post-divestiture portfolio creates room to cut G&A or leverage it with growth.
Q: "Excluding restatement costs, now that we're emerging with a cleaner portfolio and more sales visibility, do you see opportunities to reduce G&A, or is your expectation more to lever it from here as you grow?"
— Mike Albanese, Benchmark StoneX
A: "When you look at it through that lens and you exclude restatement costs, actually, it came down this quarter year-over-year... that puts me roughly at 7.8% of system sales... there's absolutely an opportunity to continue to leverage the fixed costs we have as our various businesses continue to grow." — Michael Diamond, CFO
Assessment: The ex-restatement SG&A actually declining to 7.8% of system sales is a useful, quantified sign that the underlying cost base is being managed well. It supports the view that reported margins understate the true earnings power while restatement costs run.
Value-Cohort Behavior Versus the Core Customer
An exchange sought to size the affected cohort versus the core and confirm whether the softness reflects deferral or self-service substitution.
Q: "You called out moderation of traffic... Are they deferring oil changes or they maybe trying to do it themselves?... weakness on the under $50,000 household income. How does that compare to your core customer?"
— Tristan Thomas-Martin, BMO Capital Markets
A: "Our core customer... is certainly more than $50,000. We're seeing overall resilience across the board in all groups other than really those two very specific groups. What we're seeing ultimately is a bit more churn... are we seeing intervals go up? No." — Danny Rivera, President and CEO
Assessment: The clearest statement that the softness is cohort-specific churn, not a broad deferral or DIY-substitution trend. Coupled with stable intervals, it confines the problem to a manageable, addressable segment of the customer base.
What They're NOT Saying
- A specific timeline for control remediation and a clean audit: Management reaffirmed remediation is a "multi-quarter process" with early progress, but again declined to name a target quarter for full remediation or a clean audit opinion, keeping the governance overhang's end-date undefined.
- The magnitude of the value-cohort churn: The softness is described as stable and contained, but management continues to decline to quantify what share of Take 5 traffic or revenue the affected cohorts represent, so the size of the risk remains a matter of trust.
- The shape of the post-3.0x capital-return program: Shareholder returns were named as a possibility, but the form (buyback versus dividend), size, and timing were all deferred to a year-end communication, leaving the catalyst's specifics open.
- Traffic-versus-ticket decomposition: As in prior quarters, management declined to break out how much of the Take 5 comp is traffic versus average check, which matters more now that traffic in part of the base is softening.
Market Reaction
- Pre-print setup: DRVN closed at $13.54 the day before the print, still trading near the lower end of its range after a year of de-rating through the restatement and consumer-softness narrative.
- Reaction-day session: With the release and 8:30 AM ET call landing before the open, DRVN rose to $13.83 at the close, a +2.1% move on the day.
The modest positive reaction reflects a market that was braced for worse on Take 5 traffic and instead got stabilization plus margin expansion, a below-plan restatement-cost quarter, and leverage essentially at target. The muted size of the move, rather than a sharp rally, suggests the Street is not yet pricing the post-3.0x capital-return catalyst, which is precisely the gap that supports the upgrade: the fundamentals inflected while the stock stayed cheap.
Street Perspective
Debate: Has Take 5 Stabilized or Just Paused?
Bull view: Two quarters of the same, contained, cohort-specific softness with stable intervals, rising check, and margin expansion is stabilization; the core compounder is intact and a professionalized marketing function will re-accelerate customer acquisition.
Bear view: A guided Q2 deceleration to the mid-3% range on top of persistent value-cohort churn is a business still slowing, and calling two soft quarters "stable" could be premature if the sub-$50K consumer weakens further.
Our take: The bulls have the stronger case this quarter. Stable oil-change intervals plus expanding margin and rising check are hard evidence the demand thesis holds, and the softness is confined to an identifiable, addressable cohort. The Q2 moderation is guided conservatively and sits on a ~10% two-year stack. We treat this as stabilization with monitoring, not a resumed decline.
Debate: Is the Deleveraging Story Finally a Catalyst?
Bull view: At 3.2x with the target in reach and management naming shareholder returns, the free-cash-flow story is about to pivot from debt paydown to capital return, a genuine re-rating trigger the market has not priced.
Bear view: "Possibility of returning cash" with no size or timing is not a plan, and until an actual buyback is authorized the catalyst is hypothetical while the restatement noise still clouds the numbers.
Our take: The bulls, with discipline on timing. The catalyst is not yet in hand, but it is now concrete enough and close enough (a year-end framework) to underwrite ahead of, especially with the stock de-rated and leverage essentially done. This is the piece that converts the balance-sheet story into upside.
Debate: Does the Restatement Overhang Still Justify the Discount?
Bull view: With restatement costs running below plan, remediation progressing, and a cleaner simpler portfolio, the overhang is lifting and the discount should compress as the noise clears through 2026.
Bear view: The material weaknesses are not yet remediated and a clean audit is quarters away; the equity should carry the risk premium until the controls are demonstrably fixed.
Our take: Between the two, but the discount is now more opportunity than warning. The overhang is real and the premium is warranted until remediation completes, but a de-rated stock with an improving core and an approaching capital-return catalyst is compensated for that risk. We are comfortable owning the discount here.
Model Update Needed
| Item | Prior Assumption | Suggested Change | Reason |
|---|---|---|---|
| Take 5 comp (2026) | Mid-single digit, decelerating | Mid-single digit, stabilizing | +4.5% Q1, mid-3% Q2 guide; traffic softness contained, not widening |
| Take 5 segment margin | ~34% | ~34%, expanding | +120bps YoY in Q1 |
| Net leverage | 3.3x → 3.0x by YE26 | 3.2x → 3.0x by YE26 | On track; essentially at target |
| Capital allocation (post-3.0x) | Undefined | Shift toward shareholder returns | Management named returns; limited appetite to delever further |
| Adj. EBITDA margin (ex-restatement) | Depressed by costs | Expanding ~50bps | Underlying margin improving beneath restatement noise |
Valuation impact: With leverage essentially at target, interest expense falling to ~$90M, and a capital-return program approaching, the equity-value story shifts from balance-sheet repair to free-cash-flow return against a de-rated stock. On a ~$1.20 adjusted EPS midpoint (depressed by restatement costs that roll off into 2027), the normalized earnings power supports upside as the discount compresses and the catalyst lands.
Thesis Scorecard Post-Earnings
| Thesis Point | Status | Notes |
|---|---|---|
| Bull 1 — Take 5 durable, needs-based compounder | Confirmed | 23rd straight comp; margin +120bps; traffic softness stable, intervals unchanged |
| Bull 2 — Deleveraging to 3.0x transfers value | Confirmed | 3.2x; at target; post-3.0x capital-return framework near |
| Bull 3 — Non-oil attachment second lever | Confirmed | Attachment and premium mix still rising; check strong |
| Bull 4 — Portfolio simplification sharpens returns | Confirmed | Clean 3-segment structure; ex-restatement SG&A down to 7.8% of system sales |
| Bear 1 — Consolidated growth barely positive | Neutral | Ex-restatement margin +50bps; underlying EBITDA growing |
| Bear 2 — Franchise segment structural drag | Challenged | +0.9% comp; collision stabilizing; 60% margin holds |
| Bear 3 — Balance sheet levered; refinancing risk | Challenged | 3.2x, 100% fixed; risk essentially retired |
| Bear 4 — Restatement / controls overhang | Neutral | Costs below plan; remediation progressing; end-date still undefined |
Overall: Thesis strengthened materially versus the standing view. The Q4 escalation risk on Take 5 did not play out; instead traffic stabilized and margin expanded. Deleveraging is done and the capital-return catalyst is in view. The restatement overhang is easing rather than worsening. Every load-bearing bull pillar is confirmed and three of four bear points are contained or challenged.
Action: Buy. The two conditions we set for an upgrade, Take 5 traffic stabilization and a visible capital-allocation catalyst against a de-rated stock, are both satisfied. Own it for the discount compression as the restatement noise clears and the post-3.0x capital-return program is announced. The watch item remains the sub-$50K cohort: a renewed widening of that softness would be the reason to step back to Hold.